These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 25400754)

  • 1. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
    Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
    Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
    Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.
    Zhai L; Li S; Li H; Zheng Y; Lang R; Fan Y; Gu F; Guo X; Zhang X; Fu L
    Int J Clin Exp Pathol; 2015; 8(6):7059-71. PubMed ID: 26261599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
    Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P
    J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer.
    Zhou R; Zhou X; Yin Z; Guo J; Hu T; Jiang S; Liu L; Dong X; Zhang S; Wu G
    Oncotarget; 2015 Dec; 6(42):44609-22. PubMed ID: 26587830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
    Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
    BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin.
    Takakuwa O; Oguri T; Ozasa H; Uemura T; Kunii E; Kasai D; Miyazaki M; Maeno K; Sato S
    J Thorac Oncol; 2011 Nov; 6(11):1826-32. PubMed ID: 21964527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
    He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
    Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
    Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
    Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.
    Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J
    Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
    Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
    Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
    Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
    Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression profile of apoptosis-related molecules correlated with clinicopathological factors in non-small-cell lung cancer.
    Huang JQ; Liang HL; Jin TE; Xie Z
    Int J Clin Exp Pathol; 2015; 8(9):11278-86. PubMed ID: 26647102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
    Wang X; Jiang R; Li K
    Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer.
    Misch D; Blum T; Boch C; Weiss T; Crolow C; Griff S; Mairinger T; Bauer TT; Kollmeier J
    Diagn Pathol; 2015 Apr; 10():21. PubMed ID: 25889870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
    Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
    Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of AJCC TNM Staging 7th edition in limited-stage small cell lung cancer: validation in 437 patients].
    Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):917-22. PubMed ID: 26887621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
    Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
    Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.